Prosecution Insights
Last updated: October 01, 2026

Examiner: GOLLAMUDI, NEERAJA

Tech Center 3700 • Art Units: 2841 3783

This examiner grants 73% of resolved cases

Analysis

Neeraja Gollamudi is an examiner in Tech Center 3700, Art Unit 2841. With 176 resolved cases, the examiner has an allowance rate of 72.7 percent. This is a high rate, showing that more than seven out of ten of the 176 resolved cases are eventually allowed. The data indicates a consistent history of grants in Art Unit 2841.

The interview lift is 39.9 percent, which is a very significant positive figure. This indicates that conducting an interview is associated with a substantial increase in the likelihood of allowance over the 72.7 percent baseline. Practitioners should consider an interview as a key part of their strategy, as the 39.9 percent lift shows it is an effective way to move applications toward a grant. This metric highlights the value of direct communication.

The median days to allowance for this examiner is 1192. This timeline provides a benchmark for the expected duration of the prosecution process in Tech Center 3700. With the allowance rate and the 1192 day median, practitioners can set realistic expectations for their clients. The 1192 day duration is a reliable benchmark for successful prosecution.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

72.7%
Allow Rate
+2.7% vs TC avg
217
Total Applications
+39.9%
Interview Lift
1192
Avg Prosecution Days
Based on 176 resolved cases, 2023–2026

Rejection Statute Breakdown

1.0%
§101 Eligibility
26.3%
§102 Novelty
48.8%
§103 Obviousness
22.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18821348 MEDICAL SYSTEM Non-Final OA CANON KABUSHIKI KAISHA
18641641 TEFLON LINED BRAID WIRE CATHETER FOR ENHANCED TRACKABILITY Non-Final OA DEPUY SYNTHES PRODUCTS, INC.
16720845 INTRAVASCULAR DELIVERY SYSTEM WITH CENTRALIZED STEERING Final Rejection Evalve, Inc.
17670783 CONTROLLING CONSTANT INTRAOCULAR PRESSURE USING ADAPTIVE FLOW RATES OF IRRIGATION AND ASPIRATION FLUIDS Final Rejection JOHNSON & JOHNSON SURGICAL VISION, INC.
17664339 GASTRIC PLACEMENT CONFIRMATION DEVICE Non-Final OA Regents of the University of Minnesota
18499615 SLIP LUER RETAINER Non-Final OA CareFusion 303, Inc.
18750240 MEDICAL INSTRUMENT Non-Final OA ASAHI INTECC CO., LTD.
17734639 CATHETER Final Rejection ASAHI INTECC CO., LTD.
16966391 SYRINGE ASSEMBLY Final Rejection Becton, Dickinson and Company
18804372 SAFETY CONSTRAINTS FOR A CONTROL ALGORITHM BASED DRUG DELIVERY SYSTEM Non-Final OA INSULET CORPORATION
18498275 USE OF NON-INVASIVE GLUCOSE SENSORS AND GLUCOSE RATE OF CHANGE DATA IN AN INSULIN DELIVERY SYSTEM Non-Final OA INSULET CORPORATION
18160724 EVENT DETECTION FOR DRUG DELIVERY SYSTEM Non-Final OA INSULET CORPORATION
17580249 CONDUCTIVE ELEMENT IN ADHESIVE PATCH OF ON-BODY DRUG DELIVERY DEVICE FOR BODY CHANNEL COMMUNICATION Final Rejection Insulet Corporation

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month